LATEST UPDATES » Big Data, Bigger Disease Management and Current preparations to manage the Future Health of Singaporeans       » Big Data in Clinical Research Sector       » Professor Yuk-ling Yung receives Gerard P. Kuiper Prize       » AXA Assistance on Regenerative Medicine       » Singtel – Singapore Cancer Society Race against Cancer 2015       » Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death      
Latin American link-up aims for US$1 syphilis test
Paraguayan and Uruguayan scientists are working together to develop a US$1 diagnostic test for syphilis, which they hope can be launched as early as next year.

The early-detection kit for a disease that affects three million people in Latin America would be used alongside pregnancy tests to cut cases of congenital syphilis, say the researchers, who have linked up through the UN University's Biotechnology Programme for Latin America and the Caribbean (UNU-BIOLAC), based in Venezuela.

This program, which celebrates its 25th anniversary this year, promotes biotechnology development in the region by providing training and strengthening research, and by working with regional and international scientific and academic organisations.

At two UNU-BIOLAC training courses held in Paraguay earlier this year, scientists from Paraguay and Uruguay started to work together to purify proteins from the bacteria that causes syphilis so they can be used for diagnosis with the aim of developing a cheap test for the disease.

Mónica Marín, a biochemistry professor at the University of the Republic of Uruguay, who is involved in the research, says, "In Latin America, syphilis is not concentrated in big cities but is scattered, and it is very important to make a diagnosis and give treatment when patients arrive at a health centre."

"It is much harder to get people to return to check the result of a [test] if they have to travel long distances," she says. "The benefit of this test would be direct: once the illness is detected, the patient receives immediate treatment with penicillin, enough to avoid mother-child transmission that happens during labour."

At US$25, current commercial kits for the disease's early detection are too expensive to use for systematic screening, especially when 330,000 pregnant women a year have the disease, yet receive no treatment, resulting in 110,000 babies with congenital syphilis across Latin America.

According to Marín, the plan is to launch the test next year, but the research team needs further funding to do so.

"Having a cheap screening test for congenital syphilis will offer great scientific, social and economic value since, as well as reducing the costs of healthcare services, it will improve health status in general, avoiding future problems related to syphilis.” Doris Cardona, an epidemiologist at CES University, Colombia, says

And María De La Calle, head of the perinatal infectious diseases unit at La Paz Hospital, Spain, says: "The idea of using a diagnostic test that is carried out at the same time as a pregnancy test allows early introduction of penicillin treatment, not only preventing congenital syphilis but also first-trimester abortions.”

Marín says the UNU courses allowed the researchers to share "experiences, expectations, an overall vision of the topic, problems and possible solutions".

"Partnerships are always beneficial, and when scientists from Latin American countries work together they are sending a message to the international community about the value of regional scientists," says Cardona.

De La Calle adds: "Teamwork is essential when it comes to endemic diseases affecting an entire continent. South-South cooperation will increase efficiency in the early diagnosis of syphilis in pregnancy and it will be the first step to eliminate congenital syphilis in South America."

Source: Science Development Network

Click here for the complete issue.

news Runners' High, Happy Feet — If you're Happy, and you know it 'Clap' your Feet
news Snapshot of Stem Cell Expression using Single-cell RNA Sequencing
news A Heroic Voyage — Sydney Brenner's Life in Science
news VeloX, A Minimally Invasive Prosthetic Heart Valve for treating Mitral Regurgitation
news Anti-CD25 monoclonal antibody (90Y-daclizumab) a favorable target towards systemic radio-immunotherapy in Hodgkin's Lymphoma

Credit to UBC

APBN Editorial Calendar 2015
Trends and Predictions for 2015
Robotics in Healthcare
April & May:
Universal Health Coverage
Start-Up Biotech Companies
Preventative and Translational Medicine
ASEAN Economic Community and Asia's Life Sciences Industry
Big Data: Healthcare and Drug Development
Clear Air
December (Christmas Edition):
Inspirations that last a Lifetime
APBN Editorial Calendar 2016
Korea's Biotechnology Industry
Nutrition and Allergies: Are we, Too Clean?
Medical Devices and Technology
Tobacco Smoking: The 'Real' Cost of One Cigarette
Life-Saving Opportunities: A Guide to Regenerative Medicine
Occupational Health
Water Technology
Olympics: Evolution of Sports
Respiratory: Seasonal flu viruses
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
Editorial calendar is subjected to changes. – Editor: Yuhui N Lin
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy